Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.

Shukla A, Hillegass JM, MacPherson MB, Beuschel SL, Vacek PM, Pass HI, Carbone M, Testa JR, Mossman BT. Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin. Mol Cancer. 2010 Dec 15; 9:314.

View in: PubMed

subject areas

Animals
Antibiotics, Antineoplastic
Butadienes
Cell Line, Tumor
Doxorubicin
Flow Cytometry
Humans
Mesothelioma
Mice
Mice, SCID
Microscopy, Fluorescence
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Nitriles
Reverse Transcriptase Polymerase Chain Reaction
Xenograft Model Antitumor Assays

authors with profiles

Michele Carbone, MD, PhD.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support